Inventiva’s 2020 Full-Year Financial Results Presentation

    NEXT STORY
    Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
    PREV STORY
    Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Updated Results from Phase 1 Study of Telaglenastat (CB-839) to be Presented at 2019 ASCO Genitourinary Cancer Symposium

    author_avatar
    NASDAQ Market News

    Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer

    author_avatar
    NASDAQ Market News

    Novavax Announces the Promotion of Dr. James F. Cummings to Vice President, Clinical Development and Translational Medicine

    GAITHERSBURG, Md., May 11, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), today announced that ...

    author_avatar
    NASDAQ Market News